Dispersion of hyperenhancement in late gadolinium enhancement cardiovascular magnetic resonance measured with Moran's I is associated with a decrement in LVEF 6 months after cardiotoxic chemotherapy

Documenti analoghi

• Dispersion of hyperenhancement in late gadolinium enhancement cardiovascular magnetic resonance measured with Moran's I is associated with a decrement in LVEF 6 months after cardiotoxic chemotherapy
  di: Jordan Jennifer H, et al.
  Pubblicazione: (2013-01-01)
• Progressive three-month increase in left ventricular myocardial extracellular volume fraction after receipt of anthracycline based chemotherapy
  di: Meléndez, Giselle C., et al.
  Pubblicazione: (2016)
• A Novel Approach to Early Detection of Doxorubicin Cardiotoxicity using Gadolinium Enhanced Cardiovascular Magnetic Resonance Imaging in an Experimental Model
  di: Lightfoot, James C., et al.
  Pubblicazione: (2010)
• Both intermuscular fat and LVEF decline promote heart failure symptoms in cancer survivors
  di: Reding, Kerryn W., et al.
  Pubblicazione: (2021)
• Gadolinium enhanced magnetic resonance mean voxel signal intensity within the left ventricular myocardium changes prior to ejection fraction drop after receipt of cardiotoxic chemotherapy
  di: Lightfoot, Jimmy C, et al.
  Pubblicazione: (2009)